The leadership team at OncoTartis has a long history of experience in the biotech industry, with a focus on cancer research and development. The team includes a CEO who was previously at Everon Biosciences, a Venture Partner at Maxwell Biotech Venture Fund, and a Vice President of Global Technology at Pfizer R&D. The team also includes a co-founder and CSO of Alanex Corporation, as well as a VP of Research at Everon Biosciences. All members of the leadership team have extensive experience in the field of cancer research, with education histories including degrees in Chemistry, Virology, Cancer Biology, and Experimental Oncology from some of the most prestigious universities in Russia.